Preliminary RECOVERY trial results find a monoclonal antibody (MAB) drug by Regeneron reduces the risk of death in a subset of patients with severe COVID-19.
Limited data on the uptake of contraception prior to and during crises such as the COVID-19 pandemic could mean unforeseen issues for sexual and reproductive health […]